185 related articles for article (PubMed ID: 3527821)
1. Recombinant yeast hepatitis B vaccine.
Hilleman MR
Dev Biol Stand; 1986; 63():57-62. PubMed ID: 3527821
[No Abstract] [Full Text] [Related]
2. [H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine].
Przegl Epidemiol; 1991; 45(1-2):3-10. PubMed ID: 1839076
[No Abstract] [Full Text] [Related]
3. Production and immunological analysis of recombinant hepatitis B vaccine.
Emini EA; Ellis RW; Miller WJ; McAleer WJ; Scolnick EM; Gerety RJ
J Infect; 1986 Jul; 13 Suppl A():3-9. PubMed ID: 2427590
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hepatitis B by recombinant DNA hepatitis B vaccine.
Schalm SW; Heijtink RA
Neth J Med; 1986; 29(2):42-8. PubMed ID: 3951652
[No Abstract] [Full Text] [Related]
5. [A new use for enzymes].
Gerety RG
Servir; 1986; 34(3):147-50. PubMed ID: 3016906
[No Abstract] [Full Text] [Related]
6. Hepatitis B vaccine produced in yeast.
Bitter GA; Egan KM; Burnette WN; Samal B; Fieschko JC; Peterson DL; Downing MR; Wypych J; Langley KE
J Med Virol; 1988 Jun; 25(2):123-40. PubMed ID: 3292698
[TBL] [Abstract][Full Text] [Related]
7. Significance of pre-S2 peptide of hepatitis B virus: should it be in the vaccine?
Hellström UB; Sylvan SP
Prog Med Virol; 1988; 35():76-106. PubMed ID: 2971987
[No Abstract] [Full Text] [Related]
8. The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigen.
Schellekens H; de Reus A; Peetermans JH; van Eerd PA
Postgrad Med J; 1987; 63 Suppl 2():93-6. PubMed ID: 3317363
[TBL] [Abstract][Full Text] [Related]
9. [Vaccines against hepatitis B].
Viazov SO
Vopr Virusol; 1984; 29(6):656-63. PubMed ID: 6396952
[No Abstract] [Full Text] [Related]
10. Viral hepatitis: 2. Hepatitis B vaccines.
Samaranayake LP
Dent Update; 1986 Oct; 13(9):411-4, 416. PubMed ID: 2948850
[No Abstract] [Full Text] [Related]
11. Hepatitis B: a scientific success story (almost).
Purcell RH
Prog Clin Biol Res; 1985; 182():11-43. PubMed ID: 3162171
[No Abstract] [Full Text] [Related]
12. Expression of hepatitis B virus large envelope protein in Escherichia coli and Saccharomyces cerevisiae.
Korec E; Korcová J; Palková Z; Vondrejs V; Korínek V; Reinis M; Bichko VV; Hlozánek I
Folia Biol (Praha); 1989; 35(5):315-27. PubMed ID: 2699291
[TBL] [Abstract][Full Text] [Related]
13. Human hepatitis B vaccine from recombinant yeast. 1984.
McAleer WJ; Buynak EB; Maigetter RZ; Wampler DE; Miller WJ; Hilleman MR
Biotechnology; 1992; 24():500-2. PubMed ID: 1422061
[No Abstract] [Full Text] [Related]
14. Hepatitis B vaccines.
Troisi CL; Hollinger FB
Prog Liver Dis; 1990; 9():405-42. PubMed ID: 2156306
[No Abstract] [Full Text] [Related]
15. Hepatitis B vaccines prepared from yeast by recombinant DNA techniques: memorandum from a WHO meeting.
Bull World Health Organ; 1985; 63(1):57-61. PubMed ID: 3886186
[TBL] [Abstract][Full Text] [Related]
16. Development of a hepatitis B vaccine from transformed yeast cells.
Pêtre J; Van Wijnendaele F; De Neys B; Conrath K; Van Opstal O; Hauser P; Rutgers T; Cabezon T; Capiau C; Harford N
Postgrad Med J; 1987; 63 Suppl 2():73-81. PubMed ID: 3317362
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus and polyalbumin receptors.
Thung SN; Gerber MA
Prog Liver Dis; 1986; 8():335-45. PubMed ID: 3012639
[No Abstract] [Full Text] [Related]
18. The development of novel hepatitis B vaccines.
Zuckerman AJ
Biochem Soc Symp; 1987; 53():39-49. PubMed ID: 3332768
[TBL] [Abstract][Full Text] [Related]
19. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results.
Berthelot P; Courouce AM; Eyquem A; Feldmann G; Jacob J; Ravisse P; Vacher B; Moor-Jankowski J; Muchmore E; Prince A
J Med Primatol; 1984; 13(3):119-33. PubMed ID: 6239039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
